GB1339737A - Diagnostic agents for primary hepatoma - Google Patents

Diagnostic agents for primary hepatoma

Info

Publication number
GB1339737A
GB1339737A GB5975770A GB5975770A GB1339737A GB 1339737 A GB1339737 A GB 1339737A GB 5975770 A GB5975770 A GB 5975770A GB 5975770 A GB5975770 A GB 5975770A GB 1339737 A GB1339737 A GB 1339737A
Authority
GB
United Kingdom
Prior art keywords
primary hepatoma
sediment
dec
diagnostic agents
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5975770A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44101870A external-priority patent/JPS49485B1/ja
Priority claimed from JP45066238A external-priority patent/JPS4948729B1/ja
Priority claimed from JP45075452A external-priority patent/JPS4843855B1/ja
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Priority to GB2983370A priority Critical patent/GB1340180A/en
Publication of GB1339737A publication Critical patent/GB1339737A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/549—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic with antigen or antibody entrapped within the carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1339737 Immunological preparations KOWA CO Ltd 16 Dec 1970 [18 Dec 1969 19 Feb 1970 29 July 1970 28 Aug 1970] 59757/70 Heading A5B [Also in Division B1] Serum from a primary hepatoma patient on foetal serum to be used in immunizing an animal to produce anti-alpha-1 fetoglobulin antiserum is purified before use by dialysing it against 0.1 to 0.01 w/v% aqueous acrinol solution for about 24 hours. The acrinol solution is then centrifuged to obtain the sediment, and the sediment may be purified by conventional protein fractionation methods to obtain substantially pure alpha-1-fetoglobulins.
GB5975770A 1969-12-18 1970-12-16 Diagnostic agents for primary hepatoma Expired GB1339737A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2983370A GB1340180A (en) 1969-12-18 1970-12-16 Process for the preparation of diagnostic agents for primary hepatoma

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP44101870A JPS49485B1 (en) 1969-12-18 1969-12-18
JP1433570 1970-02-19
JP45066238A JPS4948729B1 (en) 1970-07-29 1970-07-29
JP45075452A JPS4843855B1 (en) 1970-08-28 1970-08-28

Publications (1)

Publication Number Publication Date
GB1339737A true GB1339737A (en) 1973-12-05

Family

ID=27456179

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5975770A Expired GB1339737A (en) 1969-12-18 1970-12-16 Diagnostic agents for primary hepatoma

Country Status (8)

Country Link
BE (1) BE760366A (en)
CA (1) CA956554A (en)
CH (1) CH537190A (en)
DE (1) DE2062558A1 (en)
DK (1) DK131129B (en)
FR (1) FR2077560A1 (en)
GB (1) GB1339737A (en)
SE (1) SE388284B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3129049A (en) * 1960-12-05 1964-04-14 Westinghouse Electric Corp Terminal assembly shield
JPS548714A (en) * 1977-06-16 1979-01-23 Saikin Kagaku Kenkiyuushiyo Kk Production of specific antiserum
JPS55166028A (en) * 1979-06-13 1980-12-24 Mitsubishi Chem Ind Ltd Optical measurement of liquid sample
DE3532626A1 (en) * 1985-09-12 1987-03-19 Boehringer Mannheim Gmbh METHOD FOR DETERMINING A PARTNER OF AN IMMUNE REACTION

Also Published As

Publication number Publication date
DK131129B (en) 1975-06-02
CA956554A (en) 1974-10-22
BE760366A (en) 1971-06-15
DK131129C (en) 1975-12-22
SE388284B (en) 1976-09-27
CH537190A (en) 1973-05-31
FR2077560A1 (en) 1971-10-29
DE2062558A1 (en) 1971-06-24

Similar Documents

Publication Publication Date Title
AR218482A1 (en) PROCEDURE FOR THE PREPARATION OF A PROTEIN CONCENTRATE CONTAINING IMMUNOLOGICAL FACTORS OF DAIRY ORIGIN, AGAINST ESCHERIGIA COLI
GB1322000A (en) Preparation of antiserum specific for a carcinoembryonic antigen
GB1499035A (en) Antistaphylococcus human immune globulin and method of preparing same
SE8300320L (en) APPLICATION OF A SALT SOLUTION OF MONOCLONAL ANTIBODIES WITH RELATIVE HIGH SALT CONTENT IN BLOOD GROUP DETERMINATION
ES352693A1 (en) Product for and method of testing blood for the presence of hemoglobin s
Broekmans et al. Prevalence of protein C (PC) and protein S (PS) deficiency in patients with thrombotic disease
DE3378414D1 (en) Protein (pp13), process for concentrating and obtaining it, and its use
GB1322464A (en) Triglyceride assay system
GB1339737A (en) Diagnostic agents for primary hepatoma
EP0109434A4 (en) In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins.
GB1288730A (en)
Weiner Effect of centrally active drugs on the action of coumarin anticoagulants
FI881122A (en) Method for isolating basement membrane proteins from human and animal tissues
ES468932A1 (en) Protein from red blood cells and process for isolating it
JPS5283911A (en) Fat emulsion for intravenous injection
CA944688A (en) Certain diphenyl sulfones in the treatment of marek's disease
JPS5218815A (en) Novel method of immunological clinical diagnosis by means of gel-preci pitation
Willoughby Soluble complexes of antibody and complement
GB1136039A (en) Improvements relating to immunosuppressive agents
FR1500214A (en) Method for the detection of foreign constituents in particular alcohol in exhaled air
ALBINUS et al. Effect of female sex hormones and adrenocorticotrophin on feline gastrin and gastric secretions
GB1286319A (en) Method for producing antiserum for diagnosis of hepatoma
JPS51144724A (en) A process for preparing alpha-fetoprotein standard serum which is usable for a long time
CA812170A (en) Diagnostic composition for determining the presence of phenylalanine in blood
Toth et al. Immunological investigation of serum proteins in pregnancy. II. Properties of the pregnancy protein zone

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee